Earnings Ahead

AMGN - Amgen Inc

285 3.32 1.18

Amgen Inc

Amgen Inc

About

Profile

Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.


Headquarters

Thousand Oaks, California, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

AMGN



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Amgen’s obesity prospects in focus ahead of Q4 results
  • Amgen weight loss drug shows promising early data
  • Earnings week ahead: Alibaba, PepsiCo, Disney, Palantir, McDonalds, Ford and more
  • Catalyst watch: Alibaba earnings, World Defense Show, Fed speakers unleashed and Super Bowl buzz
  • U.S. govt. opens bids in Medicare drug price negotiations
  • Big Pharma earnings season in spotlight amid positive sentiment
  • PBMs ramp up lobbying efforts amid growing public scrutiny
  • FDA issues boxed warning for Amgen's osteoporosis drug
  • Honeywell's quantum computing firm valued at $5B after new fund raising round
  • Amgen may be evaluating Cytokinetics bid; CYTK wants $130-$145 a share - report (update)
  • Amgen in pact with Xeris Biopharma for Tepezza injectable
  • Florida wins FDA nod for mass drug imports from Canada (update)
  • Morgan Stanley positive on healthcare services despite election year
  • Pharma and biotech deal values spike 35% in 2023: report
  • Amgen says FDA declined full approval for lung cancer drug Lumakras
  • Amgen upgraded by BMO on underappreciated opportunity in obesity/metabolic space
  • Dividend Roundup: Alibaba, Amgen, AT&T, Southwest Airlines, and more
  • AbbVie, Amgen among firms targeted for latest Medicare inflation penalties
  • Amgen names former Novartis exec James Bradner as chief scientific officer
  • Amgen gets FDA priority review for small cell lung cancer drug

Earnings History

Date EPS / Forecast Revenue / Forecast
February 7, 2022 4.36 / 4.07 6.85B / 6.88B
November 2, 2021 4.67 / 4.29 6.71B / 6.67B Beat!
August 3, 2021 4.38 / 4.09 6.53B / 6.46B Beat!
April 27, 2021 3.7 / 4.05 5.9B / 6.26B
February 2, 2021 3.81 / 3.36 6.63B / 6.57B Beat!
October 28, 2020 4.37 / 3.93 6.42B / 6.39B Beat!
July 28, 2020 4.25 / 3.82 6.21B / 6.19B Beat!
April 30, 2020 4.17 / 3.74 6.16B / 6B Beat!
January 30, 2020 3.64 / 3.41 6.2B / 6.03B Beat!
October 29, 2019 3.66 / 3.53 5.74B / 5.63B Beat!
July 30, 2019 3.97 / 3.59 5.87B / 5.69B Beat!
April 30, 2019 3.56 / 3.48 5.56B / 5.53B Beat!
January 29, 2019 3.42 / 3.27 6.23B / 5.84B Beat!
October 30, 2018 3.69 / 3.45 5.9B / 5.78B Beat!
July 26, 2018 3.83 / 3.54 6.06B / 5.72B Beat!
April 24, 2018 3.47 / 3.22 5.55B / 5.43B Beat!
February 1, 2018 2.89 / 3.03 5.80B / 5,828M
October 25, 2017 3.27 / 3.11 5.77B / 5,756M Beat!
July 25, 2017 3.27 / 3.11 5.81B / 5.67B Beat!
April 26, 2017 3.15 / 3.11 5.46B / - Beat!
February 2, 2017 2.89 / 2.99 5.97B / 5.77B Beat!
October 27, 2016 3.02 / 2.81 5.81B / 5.71B Beat!
Date Price Open High Low Vol Change
Jan 29 281.68 280.03
283.04
279.31
2.5M 0.49%
Jan 28 280.3 280.13
283.5
279.97
2.7M -0.94%
Jan 27 282.95 277.37
283.23
276.18
3.5M 2.73%
Jan 24 275.42 276.26
277.36
273.5
2.0M -0.89%
Jan 23 277.88 273.44
278
272.32
2.5M 1.62%
 
Jan 22 273.44 272.66
275.02
272.07
3.5M -0.5%
Jan 21 274.81 272.14
276.5
270.28
3.9M 0.99%
Jan 17 272.11 276.97
276.97
269.78
3.2M 0.99%
Jan 16 269.43 268.92
270.31
267.15
2.7M 0.18%
Jan 15 268.94 269.33
272.82
268.58
3.7M 0.69%
Jan 14 267.1 271.61
271.61
264.91
2.9M -1.14%
Jan 13 270.19 262.11
270.49
261.28
3.4M 3.04%
Jan 10 262.23 260.79
264.79
260.55
2.7M -0.75%
Jan 8 264.21 261.97
264.25
259.82
2.4M 0.82%
Jan 7 262.06 260.22
265.21
259.35
3.2M 1.34%
Jan 6 258.59 259.05
261.19
257.05
4.7M -1.01%
Jan 3 261.22 260
262.08
259.79
3.0M 0.75%
Jan 2 259.28 262.18
263.58
258.31
2.4M -0.52%
Dec 31, 2024 260.64 260.75
261.54
258.85
2.0M 0.52%
Dec 30, 2024 259.3 260.83
261.56
258.5
3.0M -1.28%
Dec 27, 2024 262.65 261.1
263.5
260.51
2.2M -0.2%
Dec 26, 2024 263.18 262.21
264.73
261.76
1.6M -0.5%
Dec 24, 2024 264.49 262.48
264.55
261.36
1.5M 0.19%
Dec 23, 2024 264 263.11
264.8
260.87
3.0M 0.24%
Dec 20, 2024 263.38 269
269.61
262.21
13.7M 0.84%
Dec 19, 2024 261.19 258
261.8
253.3
4.7M 0.93%
Dec 18, 2024 258.78 265.18
267.19
258.68
4.1M -2.7%
Dec 17, 2024 265.95 265.46
270.26
264.81
4.7M -0.21%
Dec 16, 2024 266.5 270.62
272.69
266.22
3.7M -1.52%
Dec 13, 2024 270.62 272.96
274.07
270.02
2.9M -1.26%
Dec 12, 2024 274.06 273.81
275.88
272.15
3.7M 0.24%
Dec 11, 2024 273.41 276
276.28
270.58
4.5M -0.85%
Dec 10, 2024 275.75 277.86
277.9
272.36
2.8M -0.68%
Dec 9, 2024 277.63 273.16
280
272.28
3.2M 1.85%
Dec 6, 2024 272.58 275.01
275.36
271.48
4.0M -0.64%
Dec 5, 2024 274.33 277
279.04
273.15
3.2M -1.41%
Dec 4, 2024 278.26 275.81
279.41
273.86
4.2M -0.02%
Dec 3, 2024 278.32 277
281.38
276.5
5.5M 0.08%
Dec 2, 2024 278.1 282.08
282.39
276.89
4.7M -1.69%
Nov 29, 2024 282.87 279.45
283.64
277.64
2.2M 1%
Nov 27, 2024 280.07 279
282.69
278
6.6M 0.02%
Nov 26, 2024 280.01 264.22
280.34
257.8
17.0M -4.76%
Nov 25, 2024 294 293.55
297.32
293.5
4.7M -0.18%
Nov 22, 2024 294.53 290.84
295.48
288.78
3.1M 1.60%
Nov 21, 2024 289.9 288.18
291.11
284.14
3.6M 0.71%
Nov 20, 2024 287.87 281.1
288.48
278.56
4.8M 2.83%
Nov 19, 2024 279.95 277.67
281.6
275.56
3.2M 0.43%
Nov 18, 2024 278.76 279.38
281.36
276.56
3.2M -1.71%
Nov 15, 2024 283.61 291.5
291.5
279.62
5.3M -4.16%
Nov 14, 2024 295.93 297.91
298.48
292.33
3.5M -1.83%
Nov 13, 2024 301.44 306
307.43
298.91
3.7M 0.87%
Nov 12, 2024 298.84 319.59
321.22
293.8
6.7M -7.14%
Nov 11, 2024 321.81 325.91
327.58
321.61
2.5M -1.07%
Nov 8, 2024 325.28 322.48
328.25
321.28
2.0M 1.05%
Nov 7, 2024 321.91 322
322.97
318.54
2.7M 0.04%
Nov 6, 2024 321.79 325
325.39
318.17
2.2M 0.78%
Nov 5, 2024 319.29 316.16
319.52
313.02
1.5M 0.75%
Nov 4, 2024 316.91 320.58
320.58
314.61
2.1M -0.72%
Nov 1, 2024 319.22 318.69
321.7
316.91
1.8M -0.29%
Oct 31, 2024 320.16 317.69
323.4
315.65
2.7M 0%